Hemangiosarcoma is an aggressive blood vessel cancer that causes tumors on the spleen, liver, and/or heart. HSA can go unnoticed until the tumors rupture, and cause internal bleeding. Some dogs may sporadically bleed internally, with the blood reabsorbed by the body, whereas others experience profuse internal bleeding that suddenly becomes a life-threatening emergency.

In many, no signs are observed in the early disease stage.
For splenic or liver HSA, the entire spleen or affected liver lobe is removed, and followed up with chemotherapy. For cardiac HSA, chemotherapy is often recommended as the primary treatment, because surgery can be difficult. Dogs receiving chemotherapy for hemangiosarcoma need regular veterinary visits and diagnostic tests to monitor their status and prognosis. Discussing a personalized management plan with your veterinarian, and a veterinary oncologist, is important for the best outcome for your dog.
The prognosis for HSA in dogs is dependent on tumor location and stage, surgical outcome, and medical management response. Because HSA has a high potential for spreading to other organs, the survival time for surgical treatment alone is between 19 and 86 days. Different combinations of chemotherapy with surgery may provide a good quality of life for up to seven months, with a poorer prognosis for cardiac HSA.
Contact your veterinarian immediately if your dog becomes lethargic, pants heavily, has difficulty breathing, drinks excessive amounts of water, collapses, or vocalizes in pain.
Before your dog‘s condition becomes unmanageable, or they begin losing their quality of life, beginning end-of-life care discussions is vital. Learn more about pet hospice, in-home euthanasia, and our teleadvice service, or contact a Lap of Love veterinarian in your area, so you can feel fully prepared for this difficult time.